S. Miše

发表

Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats § § This study was subsidized by grants from the Ministry of Science of the Republic of Croatia and Pliva.

G. Aralica, Marko Šarlija, B. Šebečić, 1999, Journal of Physiology-Paris.

A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

G. Aralica, T. Anić, B. Šebečić, 1999, Journal of Physiology-Paris.

An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157.

I. Dobrić, T. Anić, P. Sikiric, 2006, Journal of pharmacological sciences.

Therapy for Unhealed Gastrocutaneous Fistulas in Rats as a Model for Analogous Healing of Persistent Skin Wounds and Persistent Gastric Ulcers: Stable Gastric Pentadecapeptide BPC 157, Atropine, Ranitidine, and Omeprazole

T. Anić, P. Sikiric, S. Seiwerth, 2009, Digestive Diseases and Sciences.

Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity

P. Sikiric, S. Seiwerth, R. Ručman, 1996, Digestive Diseases and Sciences.

Pentadecapeptide BPC 157, Cimetidine, Ranitidine, Bromocriptine, and Atropine Effect in Cysteamine Lesions in Totally Gastrectromized Rats (A Model for Cytoprotective Studies)

P. Sikiric, S. Seiwerth, R. Ručman, 1997, Digestive Diseases and Sciences.

Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.

L. Kalogjera, T. Anić, P. Sikiric, 2003, European journal of pharmacology.

Chronic cytoprotection: pentadecapeptide BPC 157, ranitidine and propranolol prevent, attenuate and reverse the gastric lesions appearance in chronic alcohol drinking rats.

G. Aralica, I. Prkačin, T. Anić, 2001, Journal of Physiology-Paris.

Cysteamine-colon and cysteamine-duodenum lesions in rats. Attenuation by gastric pentadecapeptide BPC 157, cimetidine, ranitidine, atropine, omeprazole, sulphasalazine and methylprednisolone

G. Aralica, I. Prkačin, T. Anić, 2001, Journal of Physiology-Paris.

Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine

I. Prkačin, T. Anić, B. Šebečić, 2001, Journal of Physiology-Paris.

Therapy effect of antiulcer agents on new chronic cysteamine colon lesion in rat

G. Aralica, I. Prkačin, T. Anić, 2001, Journal of Physiology-Paris.

Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157

G. Aralica, I. Prkačin, T. Anić, 2000, Journal of Physiology-Paris.

Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and mice

G. Aralica, I. Prkačin, T. Anić, 1999, Journal of Physiology-Paris.

The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation § § This study was subsidized by grants from Ministry of Science of Republic of Croatia and Pliva.

G. Aralica, I. Prkačin, T. Anić, 1999, Journal of Physiology-Paris.

Efficacy of Dopaminergic Agents in Peptic Ulcer Healing and Relapse Prevention — Further Indication of the Importance of Stomach Dopamine in the Stress Organoprotection Concept

M. Duvnjak, P. Sikiric, S. Seiwerth, 1995 .

Pentadecapeptide BPC 157 Beneficially Influences the Healing of Colon—Colon Anastomoses in Rats

P. Sikiric, S. Seiwerth, R. Ručman, 1997 .

Pentadecapeptide BPC 157 Interactions with Adrenergic and Dopaminergic Systems in Mucosal Protection in Stress

P. Sikiric, S. Seiwerth, R. Ručman, 1997, Digestive Diseases and Sciences.

A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC

M. Duvnjak, M. Bura, N. Skroza, 1993, Journal of Physiology-Paris.

The beneficial effect of BPC 157, a 15 amino acid peptide BPC fragment, on gastric and duodenal lesions induced by restraint stress, cysteamine and 96% ethanol in rats. A comparative study with H2 receptor antagonists, dopamine promotors and gut peptides.

M. Duvnjak, P. Sikiric, S. Seiwerth, 1994, Life sciences.

Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats

P. Sikiric, S. Seiwerth, R. Ručman, 1996, Digestive Diseases and Sciences.

Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.

I. Bilic, G. Aralica, I. Prkačin, 2001, Life sciences.

The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants

G. Aralica, I. Prkačin, T. Anić, 2000, Journal of Physiology-Paris.

The presentation and organization of adaptive cytoprotection in the rat stomach, duodenum, and colon. Dedicated to André Robert the founder of the concept of cytoprotection and adaptive cytoprotection.

V. Čapkun, M. Tonkić, T. Anić, 2006, Medical science monitor : international medical journal of experimental and clinical research.

A new gastric juice peptide, BPC - an overview of stomach (stress) organoprotection hypothesis and BPC befitial effects

M. Duvnjak, N. Skroza, J. Culig, 1993 .

[A controlled clinical trial of methylprednisolone in patients with the cholestatic form of alcoholic liver cirrhosis].

I. Hozo, Z. Rumboldt, J. Bagatin, 1996, Medicinski arhiv.

[Effects of periostin on hepatocellular carcinoma cells invasion, metastasis and prognosis].

J. Shang, Q. Wen, L. Bai, 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.

I. Prkačin, P. Sikiric, S. Seiwerth, 1999, European journal of pharmacology.

The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity

M. Duvnjak, P. Sikiric, S. Seiwerth, 1993, InflammoPharmacology.

Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin.

S. Dacic, M. Duvnjak, N. Skroza, 1993, Life sciences.

The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats.

P. Sikiric, M. Petek, I. Udovicic, 1988, European journal of pharmacology.

Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice.

N. Žarković, T. Anić, P. Sikiric, 2003, Burns : journal of the International Society for Burn Injuries.

The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.

P. Sikiric, S. Seiwerth, R. Ručman, 1997, European journal of pharmacology.

Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats

P. Sikiric, S. Seiwerth, R. Ručman, 1997, Journal of Physiology-Paris.

The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats.

L. Kalogjera, M. Duvnjak, T. Anić, 1988, European journal of pharmacology.

Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice.

G. Aralica, I. Prkačin, T. Anić, 2001, Burns : journal of the International Society for Burn Injuries.

Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.

T. Anić, P. Sikiric, S. Seiwerth, 2006, InflammoPharmacology.